BOSTON, MA, Ascidian Therapeutics, a biotechnology company, announced $40 million in Series A extension funding committed by Apple Tree Partners. Read More
NEW YORK, NY, Fillogic, is thrilled to announce the closing of its $13 million Series A funding round, led by Revelry Venture Partners (RVP). Read More